A new treatment for a deadly drug-resistant strain of tuberculosis can cure more than 90% of sufferers, according to a landmark clinical trial whose results were revealed exclusively to AFP. Doctors in Belarus treated 181 patients with the new drug, bedaquiline, in combination with other antibiotics. Of these, 168 — 93% — were cured, compared to just over half of people treated with existing drugs, according to the study results.
